[现代固定的组合在纠正高血压和脂质失调症]
Z M Galeeva1, A S Galyavich1, L V Baleeva1
1Kazan State Medical University.
Kardiologiia
|June 6, 2024
概括
本案例报告强调了使用固定组合疗法对动脉高血压和脂质失调症的个性化治疗. 埃卡梅尔® (阿姆洛迪平,利西诺普里尔,罗斯瓦斯塔丁) 有效地解决了关键的心血管疾病风险因素.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
背景情况:
- 动脉高血压和脂质失调是心血管疾病的重要危险因素.
- 缺血性心脏病经常与动脉高血压并存,需要针对性的治疗策略.
研究的目的:
- 提出一个临床案例,证明为患有动脉高血压和血脂不良症的患者选择有效治疗的个体选择.
- 评估固定三重组合治疗在管理联合心血管风险因素方面的适当性.
主要方法:
- 使用了临床病例报告方法.
- 治疗选择是基于患者特定的风险因素和临床指导方针.
- 选择了Equamer® (阿姆洛迪平 + 利西诺普里尔 + 罗斯瓦斯塔丁) 作为固定组合疗法.
主要成果:
- 选择的固定三重组合疗法 (阿姆洛迪平,利西诺普里尔,罗斯瓦斯塔丁) 被认为非常适合患者的临床形状.
- 这种组合有效地准了动脉高血压和脂质失调,这两种因素主要导致心血管风险.
结论:
- 个性化治疗选择对于管理复杂的心血管疾病至关重要.
- 固定三重组合疗法,如Equamer®,为同时解决多种心血管风险因素提供了一个合理的方法.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
421
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
421
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
647
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
647
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
157
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
157
Dosage Regimen: Fixed Dose
1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
Heart Failure Drugs: Diuretics
363
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
363
Antihypertensive Drugs: Vasodilators
503
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
503


